School Partnered Collaborative Care (SPACE) Intervention for Children with Type 1 Diabetes
Launched by UNIVERSITY OF PITTSBURGH · May 14, 2024
Trial Information
Current as of February 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This pilot cluster randomized controlled trial will examine the feasibility of a school-partnered collaborative care (SPACE) model for children with type 1 diabetes (SPACE for T1D). School districts will be randomized to the intervention or control arm in a 2:1 allocation ratio. School districts randomized to the control arm in Year 1 of the study will be invited to participate in SPACE in Year 2. All children with type 1 diabetes meeting inclusion criteria in each school district will be approached to participate through their school nurse.
All research activities will be conducted using ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of type 1 diabetes for at least 6 months
- • Attend school in one of the partnered school districts
- • Receive daily oversight from the school nurse for their diabetes
- • Managed by the Children's Hospital of Pittsburgh Diabetes center
- • Able to participate in English
- Exclusion Criteria:
- • Child has developmental delay or neuropsychiatric disorder which would preclude their participation in their diabetes care and/or completion of study questionnaires
- • Child is completely independent in diabetes care in school
Trial Officials
Christine A March, MD
Principal Investigator
Univeristy of Pittsburgh
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0